Leidos Holdings, Inc. Reports First Quarter Fiscal Year 2019 Results

April 30, 2019
- Revenues: $2.58 billion
- Diluted Earnings per Share: $1.29
- Non-GAAP Diluted Earnings per Share: $1.13
- Net Bookings: $3.3 billion (book-to-bill ratio of 1.3)

RESTON, Va., April 30, 2019 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS), a FORTUNE 500® science and technology leader, today reported financial results for the first quarter of fiscal year 2019.

Roger Krone, Leidos Chairman and Chief Executive Officer, commented: "We delivered a solid Q1 and executed well on our growth strategy while maintaining rigorous discipline on profitability and cash generation. The strong bookings, accelerating revenue growth, and substantial cash generated during the quarter demonstrate our continued momentum in creating value for our employees, customers, and shareholders."

Summary Results

Revenues for the quarter were $2.58 billion, compared to $2.44 billion in the prior year quarter, reflecting a 5.5% increase.

Operating income for the quarter was $192 million, compared to $159 million in the prior year quarter. Operating income margin increased to 7.5% from 6.5% in the prior year quarter, primarily attributable to decreases in integration and restructuring costs, lower amortization of intangible assets and an asset impairment charge in the prior year quarter. Non-GAAP operating income margin for the quarter was 9.3%, compared to 9.7% in the prior year quarter, primarily attributable to net profit write-ups in the prior year quarter.

Diluted earnings per share ("EPS") attributable to Leidos common stockholders for the quarter was $1.29, compared to $0.66 in the prior year quarter. Non-GAAP diluted EPS for the quarter was $1.13, compared to $1.03 in the prior year quarter. The weighted average diluted share count for the quarter was 147 million compared to 154 million in the prior year quarter, primarily due to stock repurchases.

Defense Solutions

Defense Solutions revenues for the quarter of $1,267 million increased by $78 million, or 6.6%, compared to the prior year quarter. The revenue increase was primarily attributable to new awards and a net increase in program volumes, partially offset by the completion of certain contracts.

Defense Solutions operating income margin for the quarter was 7.0%, compared to 7.6% in the prior year quarter. On a non-GAAP basis, operating income margin for the quarter was 8.2%, compared to 9.0% in the prior year quarter, primarily attributable to higher net profit write-ups in the prior year quarter.

Civil

Civil revenues for the quarter of $847 million increased by $18 million, or 2.2%, compared to the prior year quarter. The revenue increase was primarily attributable to new awards, partially offset by the completion of certain contracts.

Civil operating income margin for the quarter was 8.6%, compared to 8.3% in the prior year quarter. On a non-GAAP basis, operating income margin for the quarter was 11.0%, compared to 11.3% in the prior year quarter, primarily attributable to higher net profit write-ups in the prior year quarter.

Health

Health revenues for the quarter of $463 million increased by $38 million, or 8.9%, compared to the prior year quarter. The revenue increase was primarily attributable to a net increase in program volumes and new awards, partially offset by the completion of certain contracts.

Health operating income margin for the quarter was 9.7%, compared to 9.9% in the prior year quarter. On a non-GAAP basis, operating income margin for the quarter was 11.9%, compared to 12.5% in the prior year quarter, primarily attributable to reduced margins on awarded re-compete contracts.

Cash Flow Summary

Net cash provided by operating activities for the quarter was $288 million compared to $22 million in the prior year quarter. The increase was primarily due to higher advance payments from customers, improved collections of receivables and $24 million of cash paid in the prior year quarter related to the 2016 acquisition of Lockheed Martin's Information Systems & Global Solutions business ("IS&GS Business").

Net cash provided by investing activities for the quarter was $237 million compared to $96 million net cash used in investing activities in the prior year quarter. The increase in cash inflows was primarily due to proceeds received for the disposition of our commercial cybersecurity business and sale of real estate properties and cash paid in the prior year quarter related to the 2016 acquisition of the IS&GS Business, partially offset by higher payments for property, equipment and software.

Net cash used in financing activities for the quarter was $297 million compared to $91 million in the prior year quarter. The increase was primarily due to stock repurchases.

As of March 29, 2019, the Company had $536 million in cash and cash equivalents and $3.0 billion of debt.

New Business Awards

Net bookings totaled $3.3 billion in the quarter, representing a book-to-bill ratio of 1.3.

Notable recent awards received include:

  • Navy Air Systems Command : The Company was awarded a contract by the United States Navy's Naval Air Systems Command to provide flexible, ready and rapidly deployable capabilities for aviation systems worldwide. Under the Contracted Maintenance, Modification, Aircrew and Related Services contract, Leidos will provide aviation logistical services for fixed-wing, rotary-wing, unmanned aircraft vehicles and lighter than air vehicles, as well as integrally related systems and weapon systems. The multiple-award, hybrid contract has a five-year base period of performance with five optional one-year periods and a total potential value of $12.6 billion.
  • United States Army : The Company was awarded a contract by the U.S. Army Contracting Command-Redstone to provide aircraft logistics and maintenance in theaters of operations. Under the Worldwide Logistics Support Services - Contractor Logistics Support contract, the Company will provide services that support rotary-wing and fixed-wing aircraft across the globe for the U.S. Army's Multi-National Aviation Special Project Office. The multiple-award, indefinite delivery/indefinite quantity, firm-fixed-price contract has a five-year base period of performance, one five-year option ordering period and a total potential value of $25.5 billion.
  • U.S. Intelligence Community : The Company was awarded contracts valued at $884 million, if all options are exercised, by U.S. national security and intelligence clients. Though the specific nature of these contracts is classified, they all encompass mission-critical services that help to counter global threats and strengthen national security.

The Company's backlog at the end of the quarter was $21.5 billion, of which $6.1 billion was funded.

ASC 842 Update

Effective December 29, 2018, the Company adopted Accounting Standards Update 2016-02, Leases, using the modified retrospective approach.

As a result of the adoption of the new standard, the Company recorded $433 million and $486 million of right-of-use assets and lease liabilities, respectively, primarily due to its operating leases, to the Company's consolidated balance sheets. Adoption of the standard did not have a material impact on the consolidated statements of income or consolidated statements of cash flows.

Forward Guidance

As a result of the Company's year-to-date performance and updated expectations, the Company is revising its fiscal year 2019 guidance as follows:

  • Revenues of $10.5 billion to $10.9 billion;
  • Adjusted EBITDA margins of 9.9% to 10.1%;
  • Non-GAAP diluted EPS of $4.30 to $4.65, up from previous guidance of $4.25 to $4.60; and
  • Cash flows provided by operating activities at or above $825 million, up from previous guidance of at or above $725 million.

Non-GAAP diluted EPS excludes amortization of acquired intangible assets and an equity method investment, asset impairment charges, integration and restructuring costs, gain on sale of business and other tax adjustments. See Leidos' non-GAAP financial measures and the related reconciliation to GAAP measures included elsewhere in this release.

The Company does not provide a reconciliation of forward-looking adjusted EBITDA margins (non-GAAP) or non-GAAP diluted EPS to GAAP net income, due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate projected net income may vary significantly based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income at this time. The amounts of these deductions may be material and, therefore, could result in projected GAAP net income and diluted EPS being materially less than projected adjusted EBITDA margins (non-GAAP) and non-GAAP diluted EPS.

Conference Call Information

Leidos management will discuss operations and financial results in an earnings conference call beginning at 8:00 A.M. eastern time on April 30, 2019. Analysts and institutional investors may participate by dialing +1 (877) 869-3847 (toll-free U.S.) or +1 (201) 689-8261 (international callers).

A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Leidos Investor Relations website (http://ir.leidos.com).

After the call concludes, an audio replay can be accessed on the Leidos Investor Relations website or by dialing +1 (877) 660-6853 (toll-free U.S.) or +1 (201) 612-7415 (international callers) and entering conference ID 13689387.

About Leidos

Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.19 billion for the fiscal year ended December 28, 2018.

For more information, visit www.leidos.com.

Forward-Looking Statements

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of future revenues, adjusted EBITDA margins, diluted EPS (including on a non-GAAP basis) and cash flows provided by operating activities, as well as statements about future dividends, share repurchases, acquisitions and dispositions. These statements reflect our belief and assumptions as to future events that may not prove to be accurate.

Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including but not limited to: changes to our reputation and relationships with government agencies, developments in the U.S. government defense budget, including budget reductions, implementation of spending limits (sequestration) or changes in budgetary priorities; delays in the U.S. government budget process or approval of raises to the debt ceiling; delays in the U.S. government contract procurement process or the award of contracts; delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; changes in interest rates and other market factors out of our control; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our Company; our ability to effectively compete for and win contracts with the U.S. government and other customers; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by the U.S. government and commercial organizations in environmental impact and remediation projects; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; the mix of our contracts and our ability to accurately estimate costs associated with our firm-fixed-price and other contracts; our ability to realize as revenues the full amount of our backlog; cybersecurity, data security or other security threats, systems failures or other disruptions of our business; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts, including complex engineering projects; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs designed to protect us from significant product or other liability claims; our ability to manage risks associated with our international business; exposure to lawsuits and contingencies associated with the IS&GS Business; our ability to declare future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable laws and contractual agreements; our ability to grow our commercial health and infrastructure business, which could be negatively affected by our budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face. These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the U.S. Securities and Exchange Commission ("SEC"), including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest Annual Report on Form 10-K and quarterly reports on Form 10-Q, all of which may be viewed or obtained through the Investor Relations section of our website at www.leidos.com.

All information in this release is as of April 30, 2019. The Company expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in the Company's expectations. The Company also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

CONTACTS:




Investor Relations:

Media Relations:

Kelly P. Hernandez

Melissa L. Koskovich

571.526.6404

571.526.6850

ir@leidos.com

koskovichm@leidos.com

 


 

LEIDOS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in millions, except per share amounts)




Three Months Ended



March 29,
 2019


March 30,
 2018

Revenues


$

2,577



$

2,443


Cost of revenues


2,221



2,086


Selling, general and administrative expenses


166



178


Integration and restructuring costs


2



17


Asset impairment charges




7


Equity earnings of non-consolidated subsidiaries


(4)



(4)


Operating income


192



159


Non-operating income (expense):





Interest expense, net


(38)



(34)


Other income, net


92




Income before income taxes


246



125


Income tax expense


(57)



(23)


Net income attributable to Leidos common stockholders


$

189



$

102







Earnings per share:





Basic


$

1.30



$

0.67


Diluted


1.29



0.66







Weighted average number of common shares outstanding:





Basic


145



152


Diluted


147



154







Cash dividends declared per share


$

0.32



$

0.32



 

 

LEIDOS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)




March 29,
 2019


December 28,
 2018

ASSETS





Cash and cash equivalents


$

536



$

327


Receivables, net


1,894



1,877


Other current assets


430



543


Assets held for sale




92


Total current assets


2,860



2,839


Property, plant and equipment, net


220



237


Intangible assets, net


613



652


Goodwill


4,871



4,860


Operating lease right-of-use assets, net


406




Other assets


390



182




$

9,360



$

8,770


  LIABILITIES AND EQUITY





Accounts payable and accrued liabilities


$

1,893



$

1,491


Accrued payroll and employee benefits


363



473


Long-term debt, current portion


66



72


Liabilities held for sale




23


Total current liabilities


2,322



2,059


Long-term debt, net of current portion


2,966



3,052


Operating lease liabilities


305




Deferred tax liabilities


194



170


Other long-term liabilities


276



178


Stockholders' equity:





Common stock, $.0001 par value, 500 million shares authorized, 144 million and 146 million shares issued and outstanding at March 29, 2019 and December 28, 2018, respectively





Additional paid-in capital


2,767



2,966


Retained earnings


562



372


Accumulated other comprehensive loss


(35)



(30)


Total Leidos stockholders' equity


3,294



3,308


Non-controlling interest


3



3


Total equity


3,297



3,311




$

9,360



$

8,770


 

 


 

LEIDOS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)




Three Months Ended



March 29,
 2019


March 30,
 2018

Cash flows from operations:





Net income


$

189



$

102


Adjustments to reconcile net income to net cash provided by operations:





Gain on sale of business


(88)




Depreciation and amortization


58



63


Stock-based compensation


12



11


Asset impairment charges




7


Other


3



7


Change in assets and liabilities, net of effects of dispositions:





Receivables


(21)



(84)


Other current assets


(55)



(63)


Accounts payable and accrued liabilities


240



60


Accrued payroll and employee benefits


(108)



(107)


Deferred income taxes and income taxes receivable/payable


54



28


Other long-term assets/liabilities


4



(2)


Net cash provided by operating activities


288



22


Cash flows from investing activities:





Proceeds from disposition of business


171




Net proceeds from sale of assets


96




Payments for property, equipment and software


(30)



(15)


Acquisitions of businesses




(81)


Net cash provided by (used in) investing activities


237



(96)


Cash flows from financing activities:





Repurchases of stock and other


(222)



(22)


Dividend payments


(54)



(52)


Payments of long-term debt


(31)



(17)


Proceeds from issuances of stock


10



4


Other




(4)


Net cash used in financing activities


(297)



(91)


Net increase (decrease) in cash, cash equivalents and restricted cash


228



(165)


Cash, cash equivalents and restricted cash at beginning of period


369



422


Cash, cash equivalents and restricted cash at end of period


$

597



$

257



 

LEIDOS HOLDINGS, INC.
UNAUDITED SEGMENT OPERATING RESULTS
(in millions)

Effective the beginning of fiscal 2019, the Company changed the composition of its Defense Solutions reportable segment to better align the operations within the reportable segment to the customers it serves. This resulted in the identification of new operating segments within Defense Solutions. In addition, certain contracts were reassigned between the Civil and Defense Solutions reportable segments. While this activity did not have a material impact on the Company's reportable segments, prior year segments results have been recast to reflect this change.

The segment information for the periods presented was as follows:



Three Months Ended



March 29,
 2019


March 30,
 2018


Dollar

change


Percent change

Revenues:









Defense Solutions


$

1,267



$

1,189



$

78



6.6

%

Civil


847



829



18



2.2

%

Health


463



425



38



8.9

%

Total


$

2,577



$

2,443



$

134



5.5

%










Operating income (loss):









Defense Solutions


$

89



$

90



$

(1)



(1.1)

%

Civil


73



69



4



5.8

%

Health


45



42



3



7.1

%

Corporate


(15)



(42)



27



NM


Total


$

192



$

159



$

33



20.8

%










Operating income margin:









Defense Solutions


7.0

%


7.6

%





Civil


8.6

%


8.3

%





Health


9.7

%


9.9

%





Total


7.5

%


6.5

%
















NM - Not Meaningful











 


LEIDOS HOLDINGS, INC.
UNAUDITED BACKLOG BY REPORTABLE SEGMENT
(in millions)

Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts. Backlog value is based on management's estimates about volume of services, availability of customer funding and other factors, and excludes contracts that are under protest. Our estimate of backlog comprises both funded and negotiated unfunded backlog. Backlog estimates are subject to change and may be affected by several factors including modifications of contracts, non-exercise of options, foreign currency movements, etc.

Funded backlog for contracts with the U.S. government represents the value on contracts for which funding is appropriated less revenues previously recognized on these contracts. Funded backlog for contracts with non-U.S. government entities and commercial customers represents the estimated value on contracts, which may cover multiple future years, under which Leidos is obligated to perform, less revenue previously recognized on the contracts.

Negotiated unfunded backlog represents estimated amounts of revenue to be earned in the future from contracts for which funding has not been appropriated and unexercised priced contract options. Negotiated unfunded backlog does not include future potential task orders expected to be awarded under indefinite delivery/indefinite quantity ("IDIQ"), General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded or separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future task orders is anticipated.

The estimated value of backlog as of the dates presented was as follows:



March 29,
 2019


December 28,
 2018

Defense Solutions(1):





Funded backlog


$

2,983



$

2,821


Negotiated unfunded backlog


6,730



6,925


Total Defense Solutions backlog


$

9,713



$

9,746


Civil(1):





Funded backlog


$

2,038



$

2,304


Negotiated unfunded backlog


4,922



5,045


Total Civil backlog


$

6,960



$

7,349


Health:





Funded backlog


$

1,086



$

1,254


Negotiated unfunded backlog


3,721



2,483


Total Health backlog


$

4,807



$

3,737


Total:





Funded backlog


$

6,107



$

6,379


Negotiated unfunded backlog


15,373



14,453


Total backlog


$

21,480



$

20,832



(1) Prior year amounts have been recast for the contracts that were reassigned between the Defense Solutions and Civil reportable segments.

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES
(in millions, except per share amounts)

The Company uses and refers to non-GAAP operating income, non-GAAP operating margin, adjusted EBITDA, adjusted EBITDA margin and non-GAAP EPS, which are not measures of financial performance under generally accepted accounting principles in the U.S. and, accordingly, these measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be read in conjunction with the Company's consolidated financial statements prepared in accordance with GAAP.

Management believes that these non-GAAP measures provide another measure of the Company's results of operations and financial condition, including its ability to comply with financial covenants. These non-GAAP measures are frequently used by financial analysts covering Leidos and its peers. The Company's computation of its non-GAAP measures may not be comparable to similarly titled measures reported by other companies, thus limiting their use for comparability.

Non-GAAP operating income is computed by excluding the following items from net income: (i) non-operating expense, net; (ii) income tax expense; and (iii) the following discrete items and the related tax impacts:

  • Integration and restructuring costs – Represents integration, lease termination and severance costs related to the Company's acquisitions.
  • Amortization of acquired intangible assets – Represents the amortization of the fair value of the acquired intangible assets.
  • Amortization of equity method investment – Represents the amortization of the fair value of the acquired equity method investment.
  • Gain on sale of business – Represents the gain on sale of business.
  • Asset impairment charges – Represents impairments of long-lived tangible assets.
  • Other tax adjustments – Represents discrete tax items.

Non-GAAP operating margin is computed by dividing non-GAAP operating income by revenue.

Adjusted EBITDA is computed by excluding the following items from income before income taxes: (i) discrete items as identified above; (ii) interest expense; (iii) interest income; (iv) depreciation expense; and (v) amortization of intangibles.

Adjusted EBITDA margin is computed by dividing adjusted EBITDA by revenue.

Non-GAAP EPS is computed by dividing net income, adjusted for the discrete items as identified above and the related tax impacts, by the diluted weighted average number of common shares outstanding.

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share amounts)


The following tables present the reconciliation of the non-GAAP measures identified above to the most directly comparable GAAP measures:




Three Months Ended March 29, 2019



As reported


Integration and restructuring costs


Amortization of acquired intangibles


Amortization of equity method investment


Gain on sale of business


Other tax adjustments


Non-GAAP results

Operating income


$

192



$

2



$

42



$

3



$



$



$

239


Non-operating income
     (expense), net


54









(88)





(34)


Income before income
     taxes


246



2



42



3



(88)





205


Income tax (expense)
     benefit(1)


(57)



(1)



(10)



(1)



23



7



(39)


Net income attributable to
     Leidos common
     stockholders


$

189



$

1



$

32



$

2



$

(65)



$

7



$

166

















Diluted EPS attributable to
     Leidos common
     stockholders


$

1.29



$



$

0.22



$

0.01



$

(0.44)



$

0.05



$

1.13


Diluted shares


147



147



147



147



147



147



147


 



Three Months Ended March 29, 2019



As reported


Integration and restructuring costs


Amortization of acquired intangibles


Amortization of equity method investment


Gain on sale of business


Non-GAAP results

Income before income taxes


$

246



$

2



$

42



$

3



$

(88)



$

205


Depreciation expense


15











15


Amortization of intangibles


43





(42)







1


Amortization of equity method
     investment


3







(3)






Interest expense, net


38











38


EBITDA


$

345



$

2



$



$



$

(88)



$

259


EBITDA margin


13.4

%










10.1

%


(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

 

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share amounts)




Three Months Ended March 30, 2018



As reported


Integration and restructuring costs


Amortization of acquired intangibles


Amortization of equity method investment


Asset impairment charges


Non-GAAP results

Operating income


$

159



$

17



$

50



$

3



$

7



$

236


Non-operating expense, net


(34)











(34)


Income before income taxes


125



17



50



3



7



202


Income tax expense(1)


(23)



(5)



(13)





(2)



(43)


Net income attributable to Leidos
     common stockholders


$

102



$

12



$

37



$

3



$

5



$

159















Diluted EPS attributable to Leidos
     common stockholders


$

0.66



$

0.08



$

0.24



$

0.02



$

0.03



$

1.03


Diluted shares


154



154



154



154



154



154


 



Three Months Ended March 30, 2018



As reported


Integration and restructuring costs


Amortization of acquired intangibles


Amortization of equity method investment


Asset impairment charges


Non-GAAP results

Income before income taxes


$

125



$

17



$

50



$

3



$

7



$

202


Depreciation expense


13











13


Amortization of intangibles


50





(50)








Amortization of equity method
     investment


3







(3)






Interest expense, net


34











34


EBITDA


$

225



$

17



$



$



$

7



$

249


EBITDA margin


9.2

%










10.2

%


(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

 

 

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share amounts)


The following tables present the reconciliation of the non-GAAP operating income by reportable segment and Corporate:




Three Months Ended March 29, 2019



Operating income (loss)


Integration and restructuring costs


Amortization of acquired intangibles


Amortization of equity method investment


Non-GAAP operating income (loss)


Non-GAAP operating margin

Defense Solutions


$

89



$



$

15



$



$

104



8.2

%

Civil


73





17



3



93



11.0

%

Health


45





10





55



11.9

%

Corporate


(15)



2







(13)



NM


Total


$

192



$

2



$

42



$

3



$

239



9.3

%

 



Three Months Ended March 30, 2018



Operating income (loss)


Integration and restructuring costs


Amortization of acquired intangibles


Amortization of equity method investment


Asset impairment charges


Non-GAAP operating income (loss)


Non-GAAP operating margin

Defense Solutions(1)


$

90



$



$

17



$



$



$

107



9.0

%

Civil(1)


69





22



3





94



11.3

%

Health


42





11







53



12.5

%

Corporate


(42)



17







7



(18)



NM


Total


$

159



$

17



$

50



$

3



$

7



$

236



9.7

%


NM - Not Meaningful


( 1) Prior year amounts have been recast for the contracts that were reassigned between the Defense Solutions and Civil reportable segments.

 

 

Cision View original content:http://www.prnewswire.com/news-releases/leidos-holdings-inc-reports-first-quarter-fiscal-year-2019-results-300840212.html

SOURCE Leidos Holdings, Inc.

Categories: Press Releases
View all news